Cure Today: Based on their individual treatment objectives, Ankit Mangla, assistant professor at the School of Medicine, explained the significance of patient choice in treatment options for high-risk, resectable melanoma. “If you look at the overall results, using two agents is definitely more effective in achieving a pathologic complete response [no evidence of cancer] compared to a single agent,” he said.
